Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”) —a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market— has chosen bioaccess™ for its Motiva breast implant post-market clinical trial in Colombia. bioaccess™ will help the Company obtain institutional review board (IRB)/ethics committee (EC) approval at Hospital Universitario San Ignacio in Bogota to initiate its clinical trial and will also provide assistance in obtaining regulatory approval at Colombia's regulatory agency; INVIMA.

Read More